10/14/2021
The Andalusian Agency for Innovation and Development IDEA, of the Junta de Andalucía, has resolved a grant of subsidies, under a competitive competition regime, to industrial research projects and experimental development projects in Andalusia, 80% co-financed by the European Union through the European Regional Development Fund, FEDER.
(...)
7/27/2021
We are pleased to announce our new distribution partnership with 2B Scientific Ltd. On July 27th, our company sealed an exclusive distribution agreement for the commercialization of our products throughout the United Kingdom and Ireland.
(...)
7/14/2021
The Awards for Excellence in Andalusian SMEs, organized by Caixabank and Grupo Joly, were created to give visibility to the reality that Andalusia has an excellent network of SMEs and, in many cases, they are leaders in their sector and are completely focused on the international market.
(...)
7/9/2021
9th February, 2022, will be the date when the IVD manufacturers will have to adjust their business from the requirements of IVD Directive to the IVD Regulation (EU) 2017/746. This regulation provides a modern regulatory framework to the operators of the IVD market, including suppliers that provide critical products such as raw material for the in vitro diagnostic medical devices.
(...)
1/9/2021
The Insight Partners makes reports that provide in-depth analysis on the selected topic, making a review of the most important companies in the sector, and restraints and opportunities available in the market.
The Viral Antigens Market Forecast to 2027 report provides a study of Viral Antigens market using SWOT analysis (Strength, Weakness, Opportunities and Threat to the organization), and also provides an in-depth survey of the key players in the market. This survey is based on various objectives of an organization, such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization. Rekom Biotech appears as one of the ten top leading vendors of the Viral Antigens market.
(...)
